Boeing 737 MAX certification flight could come within 'a few weeks' -FAA administrator

Moderna Is a Great Company, But Don’t Buy Its Shares Until the Coronavirus Hype Fades

You've read the headlines. Stocks across the globe are getting hammered on concerns that the rapidly spreading coronavirus outbreak may inflict a bigger hit on the global economy than previously expected. But not all stocks are falling off a cliff. Instead, a few "coronavirus stocks" are actually rallying as the virus spreads. Moderna (NASDAQ:MRNA) stock is one such name.Source: Shutterstock.com Moderna is a clinical-stage biotech company which utilizes messenger RNA (or mRNA) to develop treatments and vaccines.The company is developing an mRNA-based vaccine for the coronavirus. In just 42 days, Moderna created mRNA-1273, a potential coronavirus vaccine. That vaccine has since been shipped to U.S. government researchers at the National Institute for Allergy and Infectious Diseases. Clinical trials of the vaccine will begin in April.InvestorPlace - Stock Market News, Stock Advice & Trading TipsAll of this favorable news has led to a huge rally by MRNA stock in recent weeks. So...